FDA approves bimekizumab for moderate to severe plaque psoriasis in adultsOctober 19, 2023PsoriasisPsoriatic Arthritis
Study validates use of new psoriatic arthritis prediction toolAugust 11, 2023PsoriasisPsoriatic Arthritis
Ustekinumab matches TNF inhibitors for psoriatic arthritis in 3-year, real-world studyDecember 15, 2022Psoriatic Arthritis
Analysis of PsA guidelines reveals much room for improvement on conflicts of interestOctober 6, 2022Psoriatic Arthritis
Psoriasis, psoriatic arthritis insurance coverage remains restrictiveSeptember 26, 2022Psoriatic ArthritisPsoriasis
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?September 8, 2022Psoriatic ArthritisPsoriasis
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022Psoriatic ArthritisPsoriasis
Treat-to-target strategy with tapering proves effective in PsA and axSpAJune 27, 2022Psoriatic Arthritis
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis populationMay 16, 2022Psoriatic Arthritis
